Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.79%
)
Brent Oil
91.86
(
3.37%
)
Bitcoin
74,205.31
(
-2.02%
)
News Focus
News Focus
Post# of 405179
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sox040713

Send PM Follow Ignore
Followers 55
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

sox040713

Re: scottsmith post# 203080

Wednesday, 11/08/2017 7:10:20 PM

Wednesday, November 08, 2017 7:10:20 PM

Post# of 405179
The Aruda selling sounded like fake news, that's why I asked for a source. I guess we don't need to wait long to find out how much he has sold, if any, this year in the next filing.

Dilutions are expected in pre-revenue biotechs. If that's the reason not to buy, then maybe a biotech with no clinical trial, therefore little dilutions, is a better choice. 1.63% increase in OS in the last quarter is acceptable to me for a company with three active Phase 2 trials.



FUD - Fear, uncertainty and doubt, is generally a strategic attempt to influence perception by disseminating negative and dubious or false information.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote